Preclinical Development of Human Monoclonal Antibodies for Postexposure Treatment of Crimean-Congo Hemorrhagic Fever

Project: Research project

Project Details

StatusFinished
Effective start/end date6/1/17 → 5/31/23

Funding

  • National Institute of Allergy and Infectious Diseases: $6,014,180.00